Neuroprotective effect of inhaled nitric oxide on excitotoxic-induced brain damage in neonatal rat

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Pansiot, Julien ^a   Loron, Gauthier ^a   Olivier, Paul ^a   Fontaine, Romain ^b   Charriaut Marlangue, Christiane ^a   Mercier, Jean Christophe ^a   Gressens, Pierre ^a   Baud, Olivier ^a,c  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b INSERM   (France)

^c PremUp Foundation   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUTAMATE RECEPTOR; GLUTAMIC ACID; NITRIC OXIDE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN CORTEX; BRAIN DAMAGE; CELL ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; EXCITOTOXICITY; FEMALE; GENE EXPRESSION; MALE; MICROGLIA; NEUROMODULATION; NEUROPROTECTION; NEWBORN; NONHUMAN; PERINATAL PERIOD; RAT; SIGNAL TRANSDUCTION; WHITE MATTER;

ADMINISTRATION, INHALATION; ANIMALS; ANIMALS, NEWBORN; BRAIN; MAGNETIC RESONANCE SPECTROSCOPY; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; RATS;

ANIMALIA; RATTUS;

EID: 77956217094     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010916     Document Type: Article

References (42)

1. Khwaja O, Volpe JJ (2008) Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonat Ed 93: F153-F161.
2. Hagberg H, Peebles D, Mallard C (2002) Models of white matter injury: Comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev 8: 30-38.
3. Mesples B, Plaisant F, Fontaine RH, Gressens P (2005) Pathophysiology of neonatal brain lesions: Lessons from animal models of excitotoxicity. Acta Paediatr 94: 185-190.
4. Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623-634.
5. Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695.
6. Marret S, Mukendi R, Gadisseux JF, Gressens P, Evrard P (1995) Effect of ibotenate on brain development: An excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol 54: 358-370.
7. McDonald JW, Johnston MV (1990) Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res Brain Res Rev 15: 41-70.
8. Shouman B, Fontaine RH, Baud O, Schwendimann L, Keller M, et al. (2006) Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage. Br J Pharmacol 148: 442-451.
9. Bredt DS, Snyder SH (1994) Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63: 175-195.
10. Palmer RM, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biologic activity of endothelium-derived relaxing factor. Nature 327: 524-526.
11. Barrington K, Finer N (2006) Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev CD000509.
12. Mestan KL, Marks JD, Hecox K, Huo D, Schreiber MD (2005) Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N Engl J Med 353: 23-32.
13. Dommergues MA, Patkai J, Renauld JC, Evrard P, Gressens P (2000) Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 47: 54-63.
14. Husson I, Mesplès B, Bac P, Vamecq J, Evrard P, et al. (2002) Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol 51: 82-92.
15. Baud O, Daire JL, Dalmaz Y, Fontaine RH, Krueger RC, et al. (2004) Gestational hypoxia induces white matter damage in neonatal rats: a new model of periventricular leukomalacia. Brain Pathol 14: 1-10.
16. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Annal Biochem 162: 156-159.
17. Fontaine RH, Olivier P, Massonneau V, Leroux P, Degos V, et al. (2008) Vulnerability of white matter towards antenatal hypoxia is linked to a speciesdependent regulation of glutamate receptor subunits. Proc Natl Acad Sci USA 105: 16779-16784.
18. Rani CS, Qiang M, Ticku MK (2005) Potential role of cAMP response elementbinding protein in ethanol-induced N-methyl-D-aspartate receptor 2B subunit gene transcription in fetal mouse cortical cells. Mol Pharmacol 67: 2126-2136.
19. Iadecola C (1997) Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20: 132-139.
20. Mayhan WG (2000) Nitric oxide donor-induced increase in permeability of the blood-brain barrier. Brain Res 866: 101-108.
21. Arul N, Konduri GG (2009) Inhaled nitric oxide for preterm neonates. Clin Perinatol 36: 43-61.
22. Baud O, Li J, Zhang Y, Neve RL, Volpe JJ, et al. (2004) Nitric oxide-induced cell death in developing oligodendrocytes is associated with mitochondrial dysfunction and apoptosis-inducing factor translocation. Eur J Neurosci 20: 1713-1726.
23. Li J, Baud O, Vartanian T, Volpe JJ, Rosenberg PA (2005) Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci USA 102: 9936-9941.
24. Margaill I, Allix M, Boulu RG, Plotkine M (1994) Dose-and time-dependence of L-NAME neuroprotection in transient focal ischemia in rats. Br J Pharmacol 651: 92-100.
25. Rosenberg PA, Li Y, Ali S, Altiok N, Back SA, et al. (1999) Intracellular redox state determines whether nitric oxide is toxic or neuroprotective to rat oligodendrocytes in culture. J Neurochem 73: 476-484.
26. Chiueh CC (1999) Neuroprotective properties of nitric oxide. Ann N Y Acad Sci 890: 301-311.
27. Yamamoto S, Golanov EV, Berger SB, Reis DJ (1992) Inhibition of nitric oxide synthase increases focal ischemic infarction in rat. J Cereb Blood Flow Metab 12: 717-726.
28. Zaharchuk G, Hara H, Huang PL, Fishman MC, Moskowitz MA, et al. (1997) Neuronal nitric oxide synthase mutant mice show smaller infarcts and attenuated apparent diffusion coefficient changes in the peri-infarct zone during focal cerebral ischemia. Magnet Reson Med 17: 9157-9164.
29. Iadecola C, Zhang FY, Casey R, Nagayama M, Rose ME (1997) Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 17: 9157-9164.
30. Steinhorn RH, Porta NF (2007) Use of inhaled nitric oxide in the preterm infant. Curr Opin Pediatr 19: 137-141.
31. Kinsella JP, Walsh WF, Bose CL, Gerstmann DR, Labella JJ, et al. (1999) Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet 354: 1061-1065.
32. Haynes RL, Baud O, Li J, Kinney HC, Volpe JJ, et al. (2005) Oxidative and nitrative injury in periventricular leukomalacia: a review. Brain Pathol 15: 225-233.
33. Pawloski JR, Hess DT, Stamler JS (2001) Export by red blood cells of nitric oxide bioactivity. Nature 409: 622-626.
34. Gonzalez-Zulueta M, Feldman AB, Klesse LJ, Kalb RG, Dillman JF, et al. (2000) Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc Natl Acad Sci USA 97: 436-41.
35. Cheung PY, Salas E, Etches PC, Phillipos E, Schulz R, et al. (1998) Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates. Lancet 351: 1181-1182.
36. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, et al. (2003) Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 349: 2099-2107.
37. Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, et al. (2006) Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 355: 354-364.
38. Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, et al. (2006) Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 355: 343-353.
39. Lau GC, Saha S, Faris R, Russek SJ (2004) Up-regulation of NMDAR1 subunit gene expression in cortical neurons via a PKA-dependent pathway. J Neurochem 88: 564-575.
40. Kitagawa K (2007) CREB and cAMP response element-mediated gene expression in the ischemic brain. FEBS J 274: 3210-3217.
41. Fukunaga K, Kawano T (2003) Akt is a molecular target for signal transduction therapy in brain ischemic insult. J Pharmacol Sci 92: 317-327.
42. Carlezon WA, Jr., Duman RS, Nestler EJ (2005) The many faces of CREB. Trends Neurosci 28: 436-445.